Summary
- Current Price
- As of today, ZTS price is $77.10, down -0.31% on
- Current Price All-Time High
- ZTS price is currently -69.07% below its historical high of $249.27 set on
- Market Cap
- ZTS current market cap is $32B, down -54.11% year-over-year
- PE Ratio
- ZTS current PE ratio is 12.68
- Revenue
- ZTS current annual revenue is $9.47B, up +2.28% year-over-year
- Next Earnings
- The next earnings release for ZTS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Zoetis Inc. |
| Ticker | NYSE: ZTS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | zoetis.com |
| Employees | 13,800 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $77.10 | |
| Price, 1D Change | -0.31% | |
| Market Cap | $32B | |
| TTM Dividend Yield | 2.71% | |
| PE Ratio | 12.68 | |
| Beta | 0.58 | |
| Revenue | $9.47B | |
| Revenue, 1Y Change | +2.28% | |
| EPS | $6.02 | |
| EPS, 1Y Change | +10.19% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.53 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $6.02 | |
| EPS Estimate | $6.21 | N/A |
| EPS Est. Change | +3.05% | N/A |
| Revenue | $9.47B | |
| Revenue Estimate | $9.23B | N/A |
| Revenue Est. Change | -2.46% | N/A |
| Current Price | $77.10 | |
| Price Target | $94.00 | - |
| Price Tgt. Change | +21.92% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.88 | $5.47 | -7.03% | |
| $6.34 | $6.02 | -4.96% | |
| $6.21 | N/A | +3.05% | |
| $6.53 | N/A | +8.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.25B | $9.26B | +0.04% | |
| $9.44B | $9.47B | +0.27% | |
| $9.23B | N/A | -2.46% | |
| $9.46B | N/A | -0.07% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -50.70% | |
| Price, 3Y | -59.53% | |
| Market Cap, 1Y | -54.11% | |
| Market Cap, 3Y | -63.70% | |
| Revenue, 1Y | +2.28% | |
| Revenue, 3Y | +17.17% | |
| EPS, 1Y | +10.19% | |
| EPS, 3Y | +34.01% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $77.10 | |
| SMA 200 | $103.92 | |
| SMA 50 | $75.64 | |
| EMA 200 | $101.06 | |
| EMA 50 | $77.84 | |
| MACD | $0.21 | |
| Beta | 0.58 | |
| ATR | $2.63 | |
| 14-Day RSI | 52.12 | |
| 10-Day Volatility | 37.75% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.53 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.59% | |
| Total Dividend | $2.00 | |
| $889.00M | ||
| 33.26% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $9.47B | |
| EPS | $6.02 | |
| Gross Profit | $6.67B | |
| Gross Margin | 70.49% | |
| Operating Income | $3.60B | |
| Operating Margin | 38.00% | |
| Net Income | $2.67B | |
| Net Margin | 28.23% | |
| EBITDA | $4.08B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.79 | |
| 3.03 | ||
| 1.94 | ||
| - | ||
| 7 | ||
| 4.55 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 12.68 | |
| 3.35 | ||
| 10.12 | ||
| 9.70 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $3.33B | |
| $2.31B | ||
| $15.47B | ||
| $6.77B | ||
| $12.14B | ||
| $2.24B | ||
| Total Debt | $9.30B | |
| $53.00M | ||
| $487.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $6.79B | ||
| $3.08B | ||
| $2.79B | ||
| $0.00 | ||
| $487.00M | ||
| $0.00 | ||
| $687.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $2.90B | ||
| -$748.00M | ||
| -$1.87B | ||
| Capex | $621.00M | |
| $2.28B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | → | |
| Stifel | → | |
| Citigroup | → | |
| BNP Paribas | → | |
| Piper Sandler | → | |
| UBS | → | |
| JP Morgan | → | |
| William Blair | → | |
| UBS | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with ZTS
FAQ
- What is the ticker symbol for Zoetis Inc.?
- The ticker symbol for Zoetis Inc. is NYSE:ZTS
- Does Zoetis Inc. pay dividends?
- Yes, Zoetis Inc. pays dividends. The last payment was $0.53, with an ex-dividend date on July 20, 2026
- What sector is Zoetis Inc. in?
- Zoetis Inc. is in the Healthcare sector
- What industry is Zoetis Inc. in?
- Zoetis Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Zoetis Inc. based in?
- Zoetis Inc. is headquartered in United States
- When did Zoetis Inc. go public?
- Zoetis Inc. initial public offering (IPO) was on February 1, 2013
- Is Zoetis Inc. in the S&P 500?
- Yes, Zoetis Inc. is included in the S&P 500 index
- Is Zoetis Inc. in the NASDAQ 100?
- No, Zoetis Inc. is not included in the NASDAQ 100 index
- Is Zoetis Inc. in the Dow Jones?
- No, Zoetis Inc. is not included in the Dow Jones index
- When was Zoetis Inc. last earnings report?
- Zoetis Inc.'s most recent earnings report was on August 6, 2026
- When does Zoetis Inc. report earnings?
- The next expected earnings date for Zoetis Inc. is November 3, 2026
Data Sources & References
- ZTS Official Website www.zoetis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528026000011/0001555280-26-000011-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
- ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts